Literature DB >> 31903777

Inhibition of Staphylococcus aureus and Pseudomonas aeruginosa biofilms by quatsomes in low concentrations.

Dong Dong1, Nicky Thomas2,3,4,5, Mahnaz Ramezanpour6, Alkis J Psaltis6, Shuman Huang1, Yulin Zhao1, Benjamin Thierry4,7, Peter-John Wormald6, Clive A Prestidge2,4, Sarah Vreugde6.   

Abstract

Entities:  

Keywords:  CPC-quatsome; Chronic rhinosinusitis; Pseudomonas aeruginosa; Staphylococcus aureus; biofilm; cetylpyridinium chloride

Mesh:

Substances:

Year:  2020        PMID: 31903777      PMCID: PMC6987742          DOI: 10.1177/1535370219896779

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


× No keyword cloud information.
  27 in total

Review 1.  Chronic rhinosinusitis: pathogenesis, therapy options, and more.

Authors:  Umut Can Kucuksezer; Cevdet Ozdemir; Mubeccel Akdis; Cezmi A Akdis
Journal:  Expert Opin Pharmacother       Date:  2018-10-20       Impact factor: 3.889

2.  Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis.

Authors:  Zohra Bendouah; Jean Barbeau; Walid Abou Hamad; Martin Desrosiers
Journal:  Otolaryngol Head Neck Surg       Date:  2006-06       Impact factor: 3.497

3.  Cetylpyridinium chloride and miramistin as antiseptic substances in chronic wound management - prospects and limitations.

Authors:  Carolin Fromm-Dornieden; Julian-Dario Rembe; Nadine Schäfer; Julia Böhm; Ewa K Stuermer
Journal:  J Med Microbiol       Date:  2015-02-13       Impact factor: 2.472

4.  Resistance to phenicol compounds following adaptation to quaternary ammonium compounds in Escherichia coli.

Authors:  C Soumet; E Fourreau; P Legrandois; P Maris
Journal:  Vet Microbiol       Date:  2012-02-07       Impact factor: 3.293

5.  Taking the Silver Bullet Colloidal Silver Particles for the Topical Treatment of Biofilm-Related Infections.

Authors:  Katharina Richter; Paula Facal; Nicky Thomas; Ilse Vandecandelaere; Mahnaz Ramezanpour; Clare Cooksley; Clive A Prestidge; Tom Coenye; Peter-John Wormald; Sarah Vreugde
Journal:  ACS Appl Mater Interfaces       Date:  2017-06-23       Impact factor: 9.229

6.  Formation of pH-sensitive cationic liposomes from a binary mixture of monoalkylated primary amine and cholesterol.

Authors:  Zhong-Kai Cui; Anne Bouisse; Nicolas Cottenye; Michel Lafleur
Journal:  Langmuir       Date:  2012-09-12       Impact factor: 3.882

7.  Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Microbiol Methods       Date:  2007-11-21       Impact factor: 2.363

8.  In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.

Authors:  Kien R Ha; Alkis J Psaltis; Andrew R Butcher; Peter-John Wormald; Lor Wai Tan
Journal:  Laryngoscope       Date:  2008-03       Impact factor: 3.325

9.  Antimicrobial activity of 1,3,4-oxadiazole derivatives against planktonic cells and biofilm of Staphylococcus aureus.

Authors:  Zhaojun Zheng; Qingzhong Liu; Wooseong Kim; Nagendran Tharmalingam; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2018-01-15       Impact factor: 3.808

10.  The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection.

Authors:  Sam Boase; Andrew Foreman; Edward Cleland; Lorwai Tan; Rachel Melton-Kreft; Harshita Pant; Fen Z Hu; Garth D Ehrlich; Peter-John Wormald
Journal:  BMC Infect Dis       Date:  2013-05-08       Impact factor: 3.090

View more
  2 in total

1.  Corynebacterium accolens inhibits Staphylococcus aureus induced mucosal barrier disruption.

Authors:  Shuman Huang; Karen Hon; Catherine Bennett; Hua Hu; Martha Menberu; Peter-John Wormald; Yulin Zhao; Sarah Vreugde; Sha Liu
Journal:  Front Microbiol       Date:  2022-09-14       Impact factor: 6.064

2.  Biofilms and inflammation in patients with chronic rhinosinusitis.

Authors:  Lavinia-Gianina Manciula; Ionut Isaia Jeican; Lucian Barbu Tudoran; Silviu Albu
Journal:  Med Pharm Rep       Date:  2020-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.